Along similar lines, a recent study showed that the administration of IL-1β increased the population size and functionality of adoptively transferred T cells within the tumor microenvironment, which is primarily mediated by IL-1β-stimulated host cells [91]. The gene discussed is IL1B; the disease is neoplasm.